Detalhe da pesquisa
1.
Infections in children and adolescents treated with dupilumab in pediatric clinical trials for atopic dermatitis-A pooled analysis of trial data.
Pediatr Dermatol
; 39(2): 187-196, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35083774
2.
Long-term cardiovascular disease mortality among 160 834 5-year survivors of adolescent and young adult cancer: an American population-based cohort study.
Eur Heart J
; 42(1): 101-109, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33156911
3.
Smartphone addiction may be associated with adolescent hypertension: a cross-sectional study among junior school students in China.
BMC Pediatr
; 19(1): 310, 2019 09 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31484568
4.
Real-World Effectiveness of Dupilumab in Adult and Adolescent Patients with Atopic Dermatitis: 2-Year Interim Data from the PROSE Registry.
Dermatol Ther (Heidelb)
; 14(1): 261-270, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38175364
5.
Safety and immunogenicity of a protein subunit COVID-19 vaccine (ZF2001) in healthy children and adolescents aged 3-17 years in China: a randomised, double-blind, placebo-controlled, phase 1 trial and an open-label, non-randomised, non-inferiority, phase 2 trial.
Lancet Child Adolesc Health
; 7(4): 269-279, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36803632
6.
Long-Term Efficacy and Safety of Dupilumab in Adolescents with Moderate-to-Severe Atopic Dermatitis: Results Through Week 52 from a Phase III Open-Label Extension Trial (LIBERTY AD PED-OLE).
Am J Clin Dermatol
; 23(3): 365-383, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35567671
7.
Effect of Dupilumab on Laboratory Parameters in Adolescents with Atopic Dermatitis: Results from a Randomized, Placebo-Controlled, Phase 3 Clinical Trial.
Am J Clin Dermatol
; 22(2): 243-255, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33655423
8.
Conjunctivitis in Dupilumab Clinical Trials for Adolescents with Atopic Dermatitis or Asthma.
Am J Clin Dermatol
; 22(1): 101-115, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33481203
9.
Clinically Meaningful Responses to Dupilumab in Adolescents with Uncontrolled Moderate-to-Severe Atopic Dermatitis: Post-hoc Analyses from a Randomized Clinical Trial.
Am J Clin Dermatol
; 21(1): 119-131, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31823222
10.
Responder Threshold for Patient-Oriented Eczema Measure (POEM) and Children's Dermatology Life Quality Index (CDLQI) in Adolescents with Atopic Dermatitis.
Dermatol Ther (Heidelb)
; 9(4): 799-805, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31641952